![R. Dean Peterson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
R. Dean Peterson
President at EOS Pipeline & Facilities, Inc.
Network origin in R. Dean Peterson first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Biotechnology | 22 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to R. Dean Peterson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CAMBREX CORPORATION | Pharmaceuticals: Generic | Director of Finance/CFO | |
Washington University in St. Louis | College/University | Corporate Officer/Principal | |
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Western Financial Group, Inc.
![]() Western Financial Group, Inc. Multi-Line InsuranceFinance Western Financial Group, Inc. provides insurance, financial, and banking products and services to individuals and businesses. It offers private auto, government auto, home, farm, business, and specialty insurance. The company was founded by Scott A. Tannas in 1996 and is headquartered in High River, Canada. | Multi-Line Insurance | Founder | |
INVENTRONICS LIMITED | Building Products | Chief Executive Officer | |
DIAMEDICA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Optivia Biotechnology, Inc.
![]() Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA. | Pharmaceuticals: Major | Founder | |
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
KARNALYTE RESOURCES INC. | Other Metals/Minerals | Director/Board Member Director/Board Member | |
PFB CORPORATION | Building Products | Director of Finance/CFO | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
University of Toronto | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
McMaster University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Western Life Assurance Co.
![]() Western Life Assurance Co. Multi-Line InsuranceFinance Part of The Wawanesa Mutual Insurance Co., Western Life Assurance Co. provides life, disability and health insurance products. The company is based in Winnipeg, Canada. | Multi-Line Insurance | Director/Board Member | |
University of Calgary | College/University | Undergraduate Degree | |
PACGEN LIFE SCIENCE CORPORATION | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Institute of Chartered Accountants of Alberta | Corporate Officer/Principal | ||
Genome Canada
![]() Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Chairman Chairman | |
Medical Research Council of Canada | Corporate Officer/Principal President | ||
The Ranchmen's Club
![]() The Ranchmen's Club Hotels/Resorts/Cruise linesConsumer Services The Ranchmen's Club operates as a club house. It offers its members and their guests dining options, social events and activities, and professional catering services. The company was founded by Alfred Ernest Cross, Duncan Haldane MacPherson, Herbert Samson, Hugh Wyndbram Luttrell Harford, Andrews, Lee, and Alexander in May 1891 and is headquartered in Calgary, Canada. | Hotels/Resorts/Cruise lines | Corporate Officer/Principal | |
Ischemix, Inc.
![]() Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Director/Board Member | |
Sos Children's Villages Canada | Director/Board Member | ||
The Western Communities Foundation | Director/Board Member | ||
Retrotope, Inc.
![]() Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Akinion Pharmaceuticals AB
![]() Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
Akamis Bio Ltd.
![]() Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman | |
SinuSys Corp.
![]() SinuSys Corp. Medical SpecialtiesHealth Technology SinuSys Corp. develops medical device therapies to improve the sinus health of patients with chronic sinusitis. Its products include Vent-OS sinus dilation system, Restora steroid-eluting spacer, and SinuSys product pipeline. The company was founded by Jerome Hester and Thomas A. Schreck in 2010 and is headquartered in Palo Alto, CA. | Medical Specialties | Director/Board Member | |
Phogen Ltd. | Chairman | ||
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
AshHill Investments LLC
![]() AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Investment Managers | Chief Executive Officer | |
Armetheon, Inc.
![]() Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Pharmaceuticals: Major | Founder | |
Bank West
![]() Bank West Finance/Rental/LeasingFinance Bank West offers consumer lending, commercial equipment financing, residential mortgage lending and dealership financing products. The company was founded in January 2003 and is headquartered in High River, Canada. | Finance/Rental/Leasing | Director/Board Member | |
Chronos Therapeutics Ltd.
![]() Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman | |
Mironid Ltd.
![]() Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Macrophage Pharma Ltd.
![]() Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Chairman | |
Renexxion LLC
![]() Renexxion LLC Pharmaceuticals: MajorHealth Technology Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder | |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
Canada | 26 |
United States | 14 |
United Kingdom | 10 |
Sweden | 2 |
Ireland | 2 |
Sectoral
Health Technology | 26 |
Finance | 7 |
Consumer Services | 6 |
Commercial Services | 4 |
Non-Energy Minerals | 3 |
Operational
Director/Board Member | 142 |
Corporate Officer/Principal | 49 |
Chairman | 40 |
Independent Dir/Board Member | 34 |
President | 31 |
Most connected contacts
Insiders | |
---|---|
Calvin Stiller | 38 |
Mark Wayne | 26 |
Ian S. Brown | 26 |
Luke Beshar | 19 |
Peter G. Milner | 18 |
David Allan | 16 |
Michael G. Moore | 16 |
Albert Agro | 13 |
Niclas Stiernholm | 13 |
Scott Tannas | 13 |
James DeMesa | 13 |
Henry Friesen | 12 |
Thomas Reynolds | 10 |
James Parsons | 10 |
Robert L. Kirkman | 9 |
- Stock Market
- Insiders
- R. Dean Peterson
- Company connections